{"transactions":[{"id":4639275,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18360,"kind":"person","name":"Hackman Jeffrey S.","position":1,"cik":"0001926254","reported_name":"Hackman Jeffrey S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-10-13T20:05:17.000Z","date":"2026-10-12","kind":"grant","planned":false,"acquired":true,"shares":2224,"price":5.53,"value":12298.72,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Issuer's common shares were acquired pursuant to the Fennec Pharmaceuticals Inc. Employee Stock Purchase Plan (\"ESPP\") for the ESPP purchase period of April 9, 2026 through October 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on the Nasdaq Capital Market on April 9, 2026."}],"balance_after":69685,"source":{"system":"sec-edgar","filing":"0001926254-26-000018","document":"form4-10132026_041008.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1926254/000192625426000018/form4-10132026_041008.xml","form_type":"4"}},{"id":4635083,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18360,"kind":"person","name":"Hackman Jeffrey S.","position":1,"cik":"0001926254","reported_name":"Hackman Jeffrey S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-10-02T00:05:10.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":1159,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":67461,"source":{"system":"sec-edgar","filing":"0001926254-26-000016","document":"form4-10012026_041005.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000192625426000016/form4-10012026_041005.xml","form_type":"4"}},{"id":671915,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18360,"kind":"person","name":"Hackman Jeffrey S.","position":1,"cik":"0001926254","reported_name":"Hackman Jeffrey S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-09-01T00:10:33.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":1159,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":66302,"source":{"system":"sec-edgar","filing":"0001926254-26-000014","document":"form4-09012026_120929.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000192625426000014/form4-09012026_120929.xml","form_type":"4"}},{"id":698732,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18360,"kind":"person","name":"Hackman Jeffrey S.","position":1,"cik":"0001926254","reported_name":"Hackman Jeffrey S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-08-03T20:05:12.000Z","date":"2026-07-31","kind":"grant","planned":false,"acquired":true,"shares":1159,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":65143,"source":{"system":"sec-edgar","filing":"0001926254-26-000012","document":"form4-08032026_040806.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000192625426000012/form4-08032026_040806.xml","form_type":"4"}},{"id":720873,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18360,"kind":"person","name":"Hackman Jeffrey S.","position":1,"cik":"0001926254","reported_name":"Hackman Jeffrey S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-07-01T20:36:17.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":1159,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":63984,"source":{"system":"sec-edgar","filing":"0001926254-26-000010","document":"form4-07012026_080713.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000192625426000010/form4-07012026_080713.xml","form_type":"4"}},{"id":756822,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18360,"kind":"person","name":"Hackman Jeffrey S.","position":1,"cik":"0001926254","reported_name":"Hackman Jeffrey S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-06-01T20:05:07.000Z","date":"2026-05-31","kind":"grant","planned":false,"acquired":true,"shares":1159,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":62825,"source":{"system":"sec-edgar","filing":"0001926254-26-000008","document":"form4-06012026_040603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000192625426000008/form4-06012026_040603.xml","form_type":"4"}},{"id":795385,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18360,"kind":"person","name":"Hackman Jeffrey S.","position":1,"cik":"0001926254","reported_name":"Hackman Jeffrey S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-05-01T20:05:17.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":true,"shares":1159,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":61666,"source":{"system":"sec-edgar","filing":"0001926254-26-000006","document":"form4-05012026_040503.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000192625426000006/form4-05012026_040503.xml","form_type":"4"}},{"id":819169,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18360,"kind":"person","name":"Hackman Jeffrey S.","position":1,"cik":"0001926254","reported_name":"Hackman Jeffrey S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2026-04-02T20:05:26.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":5.77,"value":1154000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"On March 31, 2026, granted incentive stock options to purchase 200,000 shares of the issuers common shares pursuant to the Issuer's 2020 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-third of the shares subject to this option may be exercised as of March 31, 2027 (\"Vesting Commencement Date\"). One twenty-fourth of the shares subject to this option shall vest and may be exercised as of the last day of each month following the Vesting Commencement Date. As of March 31, 2029, 100% of the total number of shares subject to this option shall be vested."}],"balance_after":725000,"derivative":{"exercise_price":5.77,"exercise_date":"2027-03-31","expiration_date":"2036-03-31","underlying":"Common Shares","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001926254-26-000004","document":"form4-04022026_040412.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000192625426000004/form4-04022026_040412.xml","form_type":"4"}},{"id":819168,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18360,"kind":"person","name":"Hackman Jeffrey S.","position":1,"cik":"0001926254","reported_name":"Hackman Jeffrey S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-04-02T20:05:26.000Z","date":"2026-03-28","kind":"exercise","planned":false,"acquired":true,"shares":13943,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":60507,"source":{"system":"sec-edgar","filing":"0001926254-26-000004","document":"form4-04022026_040412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000192625426000004/form4-04022026_040412.xml","form_type":"4"}},{"id":819167,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18360,"kind":"person","name":"Hackman Jeffrey S.","position":1,"cik":"0001926254","reported_name":"Hackman Jeffrey S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-04-02T20:05:26.000Z","date":"2026-03-31","kind":"exercise","planned":false,"acquired":true,"shares":1159,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":46564,"source":{"system":"sec-edgar","filing":"0001926254-26-000004","document":"form4-04022026_040412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000192625426000004/form4-04022026_040412.xml","form_type":"4"}},{"id":819166,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18360,"kind":"person","name":"Hackman Jeffrey S.","position":1,"cik":"0001926254","reported_name":"Hackman Jeffrey S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-04-02T20:05:26.000Z","date":"2026-03-31","kind":"exercise","planned":false,"acquired":true,"shares":16695,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents settlement of PSUs that vested on March 31, 2026."}],"balance_after":45405,"source":{"system":"sec-edgar","filing":"0001926254-26-000004","document":"form4-04022026_040412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000192625426000004/form4-04022026_040412.xml","form_type":"4"}},{"id":892932,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18360,"kind":"person","name":"Hackman Jeffrey S.","position":1,"cik":"0001926254","reported_name":"Hackman Jeffrey S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-02-19T23:44:43.000Z","date":"2026-02-18","kind":"exercise","planned":false,"acquired":true,"shares":13710,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents settlement of PSUs that vested on February 18, 2026."}],"balance_after":28710,"source":{"system":"sec-edgar","filing":"0001926254-26-000002","document":"form4-02192026_110240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000192625426000002/form4-02192026_110240.xml","form_type":"4"}},{"id":1142272,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18360,"kind":"person","name":"Hackman Jeffrey S.","position":1,"cik":"0001926254","reported_name":"Hackman Jeffrey S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-05-19T21:42:21.000Z","date":"2025-05-19","kind":"purchase","planned":false,"acquired":true,"shares":13965,"price":6.99,"value":97615.35,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Transaction Code P - Open market or private purchase of non-derivative or derivative security"}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001415889-25-013673","document":"form4-05192025_090517.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000141588925013673/form4-05192025_090517.xml","form_type":"4"}},{"id":1142271,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18360,"kind":"person","name":"Hackman Jeffrey S.","position":1,"cik":"0001926254","reported_name":"Hackman Jeffrey S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-05-19T21:42:21.000Z","date":"2025-05-16","kind":"purchase","planned":false,"acquired":true,"shares":1035,"price":6.75,"value":6986.25,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Transaction Code P - Open market or private purchase of non-derivative or derivative security"}],"balance_after":1035,"source":{"system":"sec-edgar","filing":"0001415889-25-013673","document":"form4-05192025_090517.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000141588925013673/form4-05192025_090517.xml","form_type":"4"}},{"id":1179097,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18360,"kind":"person","name":"Hackman Jeffrey S.","position":1,"cik":"0001926254","reported_name":"Hackman Jeffrey S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2025-04-03T23:13:43.000Z","date":"2025-03-28","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"On March 28, 2025, Jeffrey Hackman was granted incentive stock options to purchase 50,000 shares of the issuers common shares pursuant to the Issuer's 2020 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-third of the shares subject to this option may be exercised as of March 28, 2026 (\"Vesting Commencement Date\"). One twenty-fourth of the shares subject to this option shall vest and may be exercised as of the last day of each month following the Vesting Commencement Date. As of February 29, 2028, 100% of the total number of shares subject to this option shall be vested"}],"balance_after":525000,"derivative":{"exercise_price":6.5,"exercise_date":"2026-03-28","expiration_date":"2035-03-28","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-25-010065","document":"form4a-04032025_110440.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000141588925010065/form4a-04032025_110440.xml","form_type":"4/A","original_submission_date":"2025-04-03"}},{"id":1179096,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18360,"kind":"person","name":"Hackman Jeffrey S.","position":1,"cik":"0001926254","reported_name":"Hackman Jeffrey S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Share Unit","published_at":"2025-04-03T23:13:43.000Z","date":"2025-03-28","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On March 28, 2025, Jeffrey Hackman was awarded restricted share units to acquire 75,000 shares of the issuer's common shares pursuant to the issuer's 2020 Equity Incentive Plan"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the shares subject to this award shall be released from restriction as of March 28, 2026 (the \"Vesting Commencement Date\"). One twenty-fourth of the shares subject to this award may be released from restriction as of the last day of each month following the Vesting Commencement Date. As of February 29, 2028 and thereafter, 100% of the total number of shares subject to this award shall be released from restriction."}],"balance_after":475000,"derivative":{"exercise_price":0,"exercise_date":"2026-03-28","expiration_date":"2035-03-28","underlying":"Common Shares","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001415889-25-010065","document":"form4a-04032025_110440.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000141588925010065/form4a-04032025_110440.xml","form_type":"4/A","original_submission_date":"2025-04-03"}},{"id":1179095,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18360,"kind":"person","name":"Hackman Jeffrey S.","position":1,"cik":"0001926254","reported_name":"Hackman Jeffrey S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2025-04-03T22:12:54.000Z","date":"2025-03-28","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"On March 28, 2025, Jeffrey Hackman was granted incentive stock options to purchase 50,000 shares of the issuers common shares pursuant to the Issuer's 2020 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-third of the shares subject to this option may be exercised as of March 28, 2026 (\"Vesting Commencement Date\"). One twenty-fourth of the shares subject to this option shall vest and may be exercised as of the last day of each month following the Vesting Commencement Date. As of February 29, 2028, 100% of the total number of shares subject to this option shall be vested"}],"balance_after":450000,"derivative":{"exercise_price":6.5,"exercise_date":"2026-03-28","expiration_date":"2035-03-28","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-25-010057","document":"form4-04032025_100450.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000141588925010057/form4-04032025_100450.xml","form_type":"4"}},{"id":1179094,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18360,"kind":"person","name":"Hackman Jeffrey S.","position":1,"cik":"0001926254","reported_name":"Hackman Jeffrey S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Share Unit","published_at":"2025-04-03T22:12:54.000Z","date":"2025-03-28","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On March 28, 2025, Jeffrey Hackman was awarded restricted share units to acquire 75,000 shares of the issuer's common shares pursuant to the issuer's 2020 Equity Incentive Plan"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the shares subject to this award shall be released from restriction as of March 28, 2026 (the \"Vesting Commencement Date\"). One twenty-fourth of the shares subject to this award may be released from restriction as of the last day of each month following the Vesting Commencement Date. As of February 29, 2028 and thereafter, 100% of the total number of shares subject to this award shall be released from restriction."}],"balance_after":75000,"derivative":{"exercise_price":0,"exercise_date":"2026-03-28","expiration_date":"2035-03-28","underlying":"Common Shares","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001415889-25-010057","document":"form4-04032025_100450.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000141588925010057/form4-04032025_100450.xml","form_type":"4"}},{"id":1429024,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18360,"kind":"person","name":"Hackman Jeffrey S.","position":1,"cik":"0001926254","reported_name":"Hackman Jeffrey S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2024-08-19T22:59:29.000Z","date":"2024-08-15","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":5.58,"value":2232000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On August 15, 2024, Jeffrey Hackman was granted incentive stock options to purchase 400,000 shares of the issuers common shares pursuant to the Issuer's 2020 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the shares subject to this option may be exercised as of August 5, 2025 (\"Vesting Commencement Date\"). One twenty-fourth of the shares subject to this option shall vest and may be exercised as of the last day of each month following the Vesting Commencement Date. As of August 5, 2027, 100% of the total number of shares subject to this option shall be vested."}],"balance_after":400000,"derivative":{"exercise_price":5.58,"exercise_date":"2025-08-05","expiration_date":"2034-08-05","underlying":"Common Shares","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001415889-24-021637","document":"form4-08192024_100825.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000141588924021637/form4-08192024_100825.xml","form_type":"4"}},{"id":1771968,"issuer":{"id":94670,"kind":"organization","name":"Comera Life Sciences Holdings, Inc.","symbol":"CMRA"},"owners":[{"id":18360,"kind":"person","name":"Hackman Jeffrey S.","position":1,"cik":"0001926254","reported_name":"Hackman Jeffrey S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks."}}],"security":"Stock Option (Right to Purchase)","published_at":"2023-09-28T16:06:05.000Z","date":"2023-09-27","kind":"grant","planned":false,"acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying the stock option vest on September 27, 2024, with the remaining shares vesting on a monthly basis on the 27th day of each month thereafter, in each case, subject to continuous service to the issuer, such that the option shall be fully vested on September 27, 2027."}],"balance_after":600000,"derivative":{"exercise_price":0.376,"expiration_date":"2033-09-27","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001062993-23-018577","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1907685/000106299323018577/form4.xml","form_type":"4"}},{"id":2010311,"issuer":{"id":94670,"kind":"organization","name":"Comera Life Sciences Holdings, Inc.","symbol":"CMRA"},"owners":[{"id":18360,"kind":"person","name":"Hackman Jeffrey S.","position":1,"cik":"0001926254","reported_name":"Hackman Jeffrey S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks."}}],"security":"Stock Option (Right to Purchase)","published_at":"2023-02-16T18:20:01.000Z","date":"2023-02-14","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying the stock option vest on February 14, 2024, with the remaining shares vesting on a monthly basis on the 14th day of each month thereafter, in each case, subject to continuous service to the issuer, such that the option shall be fully vested on February 14, 2027."}],"balance_after":100000,"derivative":{"exercise_price":1.3,"expiration_date":"2033-02-14","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001062993-23-003833","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1907685/000106299323003833/form4.xml","form_type":"4"}},{"id":2160854,"issuer":{"id":94670,"kind":"organization","name":"Comera Life Sciences Holdings, Inc.","symbol":"CMRA"},"owners":[{"id":18360,"kind":"person","name":"Hackman Jeffrey S.","position":1,"cik":"0001926254","reported_name":"Hackman Jeffrey S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-09-12T17:23:31.000Z","date":"2022-09-09","kind":"purchase","acquired":true,"shares":47600,"price":2.06,"value":98056.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.00 to $2.10, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."}],"balance_after":47600,"source":{"system":"sec-edgar","filing":"0001062993-22-019482","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1907685/000106299322019482/form4.xml","form_type":"4"}},{"id":2187723,"issuer":{"id":94670,"kind":"organization","name":"Comera Life Sciences Holdings, Inc.","symbol":"CMRA"},"owners":[{"id":18360,"kind":"person","name":"Hackman Jeffrey S.","position":1,"cik":"0001926254","reported_name":"Hackman Jeffrey S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks."}}],"security":"Stock Option (Right to Purchase)","published_at":"2022-08-11T18:14:07.000Z","date":"2022-08-09","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest over four (4) years, with twenty-five percent (25%) of the shares of Common Stock underlying the option vesting on August 9, 2023 and the remainder vesting in equal monthly installments thereafter."}],"balance_after":300000,"derivative":{"exercise_price":2.77,"expiration_date":"2032-08-09","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001062993-22-017760","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1907685/000106299322017760/form4.xml","form_type":"4"}}]}